2.5% iPAAG

TRANSFORMING ANIMAL
HEALTH WORLDWIDE

Innovative Solution for Osteoarthritis in Horses and Dogs

Arthramid® 2.5% injectable polyacrylamide hydrogel (iPAAG) is a pioneering treatment. Implanted into the joint itself, rather than simply masking pain, it defies conventional treatments by restoring joint health and function.

2.5% iPAAG is created by a unique patented process called IL-X in-line cross-linking which affords clear differences in composition, manufacturing, and injection techniques, as well as its ability to interact with surrounding tissues.

Ultimately, these characteristics determine the safety and effectiveness of Arthramid. As a cutting-edge treatment, Arthramid is trusted by veterinarians, owners, and trainers alike.

LEARN MORE

How Does Arthramid Work?

Arthramid is administered into the joint and has a targeted action on the synovial membrane (synovium). Synovitis is known to be the single most important factor that contributes to the pain of osteoarthritis and joint lameness.

Arthramid integrates into the synovial membrane stabilising the joint capsule and increasing elasticity, which in turn reduces the onset of synovitis and its harmful effects. The improved function of the synovium further improves the nature of the synovial fluid within the joint itself, ultimately restoring the joint to healthy function (homeostasis) and disrupting the vicious cycle of OA. Treatment therefore gives superior and long-term benefits.

LEARN MORE

Why Use Arthramid?

Animals of any age can develop osteoarthritis (OA). Arthramid can be used in any synovial joint with visible signs of lameness, including pain, effusion (fluid), or reaction to palpation/flexion. Treatment of multiple joints at one time is safe, and arthritic conditions which are recent (acute) or longer term (chronic) both respond well.

The ideal candidate for Arthramid is where a veterinary examination has localized the pain to the joint and osteoarthritis or synovitis has been confirmed.

CANDIDATE CRITERIA

Precision Manufacturing

Tour the Contura manufacturing facility in Denmark, Copenhagen
Watch video

Precision Medicine

NOT ALL HYDROGELS ARE
CREATED EQUAL
  • Studies show over 82.5% of patients respond to treatment with Arthramid
  • Arthramid is not simply a lubricant or pain killer. It’s unique biomedical technology that helps restore joint function.
  • When compared to other hydrogels or treatments for osteoarthritis, research shows Arthramid is better and lasts longer with proven efficacy.
  • Over 20+ years of research in animals and humans, Contura continues its committmetn to ongoing research and development.

Learn more about Contura manufacturing.

LEARN ABOUT CONTURA

Learn More About Arthramid

ABOUT ARTHRAMID
LATEST NEWS
RESOURCES & EDUCATION

Arthramid Testimonials

Dr Stuart Vallance
ADVANTAGE EQUINE VETERINARY PRACTICE – VIC, AUSTRALIA
"In my opinion, it can minimise the use of intra-articular corticosteroids or other joint therapies used in Thoroughbred stables”
Dr Marcus Allan
TAURANGA VETERINARY SERVICES LTD
– NEW ZEALAND
"Arthramid has been a great option for horse owners of all levels to provide effective osteoarthritis management.”
Dr Emma Wood
VETERINARIAN
"On his non gallop days he would complete 4000m of cantering daily, this is a lot of miles on his joints and I do not believe we could have kept him sound without the use of Arthramid.”
Dr Marc Koene
TIERKLINIK LÜSCHE GMBH EQUINE HOSPITAL – NORTHER GERMANY
"We have injected over a thousand horses and have found it to be very safe. It has been a major game-changer in the way we treat OA in our patients.”
Dr Florent David
EQUINE VETERINARY MEDICAL CENTRE
– DOHA, QATAR
"Arthramid is a very potent and very safe drug to use, and I recommend it to my clients and other vets"
Dr Kim McKeller
AK & K EQUINE SERVICES
– VIC, AUSTRALIA
"I have been using Arthramid for years treating TB’s, SB’s and equestrian horses. It’s simply the best treatment we have for arthritis and is my first port of call for all lamenesses involving non-septic joint inflammation”
Dr Bruce Connally
WYOMING EQUINE - WYOMING
"The most impressive part has been the duration of efficacy of at least one year in almost every case."
Dr Bob Peters
MCKINLAY & PETERS EQUINE HOSPITAL - NEWMAN LAKE, WA
"In my opinion, it is efficacious, long-lasting and lower risk to cartilage than many alternatives."
Dr Charley McColough
PALM BEACH EQUINE - WELLINGTON, FL
"By incorporating Arthramid into my practice, I’m able to use far fewer steroids while still achieving excellent results, which gives me greater peace of mind for the long-term well-being of the horses under my care."
Franciso Alvarez
Dr Fransico Alvarez
LONE STAR EQUINE SPORTS MEDICINE - MONTGOMERY, TX
"This innovative treatment supports improved mobility and overall performance, making it an invaluable tool for maintaining the health of equine athletes."
Dr Libby Fedorko
WEST COAST EQUINE MEDICINE - TEMECULA, CA
“Arthramid has become a cornerstone of my joint health treatment protocol.  In my experience, it consistently delivers superior results compared to traditional treatments. Whether used alone or in combination with steroids, Arthramid leads to improved joint health, enhanced overall performance, and longer-lasting results."
Dr Jennifer Groon
THE FEINER EQUINE - WELLINGTON, FL
"Arthramid helps meditate lameness and, I believe, prevent further joint breakdown in these patients."
Dr Melissa Kielty
PIONEER VETERINARY SERVICES - ALAMO, CA
“Arthramid is proving to be a mainstay in my practice. It has been particularly great for me in stifles, I love that it has long duration and no negative metabolic effects”
Dr. Chelsea Fishenfeld
EQUINE MEDICAL ASSOCIATES - LAKE FOREST, CA
“The owner of every horse I have treated with Arthramid is so grateful for the improved performance it has given their athletes. It has been particularly beneficial for use in patients with PPIID or ID as a safer solution. I cannot speak highly enough of Arthramid!”
READ MORE

Explore Additional Arthramid Videos

Arthramid Insights from Dr. Jason Lowe
Watch video
Arthramid Mechanism of Action
Watch video

Talk to us for more information

Contact Us

Get The White Paper